- ZF (Northville, MI)
- …to remove barriers so that every member of ZF can rise to their full potential. We aim to embed this in our legacy through how we operate and build our products as ... to remove barriers so that all our employees can rise to their full potential. We aim to embed this vision in our legacy through how we operate and build our… more
- ZF (Duncan, SC)
- …to remove barriers so that every member of ZF can rise to their full potential. We aim to embed this in our legacy through how we operate and build our products as ... to remove barriers so that all our employees can rise to their full potential. We aim to embed this vision in our legacy through how we operate and build our… more
- ZF (Duncan, SC)
- …to remove barriers so that every member of ZF can rise to their full potential. We aim to embed this in our legacy through how we operate and build our products as ... to remove barriers so that all our employees can rise to their full potential. We aim to embed this vision in our legacy through how we operate and build our… more
- Stanford University (Stanford, CA)
- …risk variants for common and rare diseases and could reveal targets for therapeutics that aim to precisely tune cellular functions - if only we could map the complex ... more information and recent work, seehttps://www.engreitzlab.organdhttps://kundajelab.github.io/) Project overview: We aim to develop and apply computational models to interpret… more
- New York University (New York, NY)
- …diseases, including neurodevelopmental disorders and neurodegenerative diseases. The project will aim to identify novel relevant mechanisms both in healthy brains ... disease that we are focusing on is Angelman syndrome for which we aim to identify neural alterations, biomarkers and therapeutics. The project will employ rodent… more
- Sumitomo Pharma (Salem, OR)
- …products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to ... products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to… more
- Sumitomo Pharma (Frankfort, KY)
- …products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to ... products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to… more
- ZF (Marysville, MI)
- …to remove barriers so that every member of ZF can rise to their full potential. We aim to embed this in our legacy through how we operate and build our products as ... to remove barriers so that all our employees can rise to their full potential. We aim to embed this vision in our legacy through how we operate and build our… more
- ZF (Vernon Hills, IL)
- …to remove barriers so that every member of ZF can rise to their full potential. We aim to embed this in our legacy through how we operate and build our products as ... to remove barriers so that all our employees can rise to their full potential. We aim to embed this vision in our legacy through how we operate and build our… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …Everyone at Kite is grounded by one common goal - curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work. We are ... Everyone at Kite is grounded by one common goal - curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work. We are… more